1. Home
  2. BBAR vs NVCR Comparison

BBAR vs NVCR Comparison

Compare BBAR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco BBVA Argentina S.A. ADS

BBAR

Banco BBVA Argentina S.A. ADS

HOLD

Current Price

$14.80

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$16.22

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAR
NVCR
Founded
1886
2000
Country
Argentina
Switzerland
Employees
6493
N/A
Industry
Commercial Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.0B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
BBAR
NVCR
Price
$14.80
$16.22
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$17.00
$28.08
AVG Volume (30 Days)
884.8K
1.1M
Earning Date
05-20-2026
04-30-2026
Dividend Yield
2.04%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$18.32
$7.72
Revenue Next Year
$11.04
$6.74
P/E Ratio
$26.78
N/A
Revenue Growth
N/A
8.28
52 Week Low
$7.76
$9.82
52 Week High
$22.47
$21.45

Technical Indicators

Market Signals
Indicator
BBAR
NVCR
Relative Strength Index (RSI) 39.90 38.32
Support Level $13.43 $14.84
Resistance Level $15.68 $18.43
Average True Range (ATR) 0.70 0.74
MACD 0.15 -0.31
Stochastic Oscillator 35.18 9.74

Price Performance

Historical Comparison
BBAR
NVCR

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: